Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,225,000 | 1,721,828 | 717,350 | 543,223 | 270,123 |
| Marketable Securities | 1,140,000 | 1,183,715 | 1,293,191 | 1,361,509 | 1,394,982 |
| Receivables | 1,050,000 | 962,985 | 913,818 | 1,070,509 | 959,955 |
| Inventories | 703,000 | 621,389 | 600,863 | 565,597 | 590,343 |
| Income taxes - deferred | 167,000 | N/A | N/A | N/A | 148,370 |
| Other current assets | 0 | 195,505 | 213,598 | 0 | 0 |
| TOTAL | $4,386,000 | $4,794,579 | $3,935,805 | $3,753,321 | $3,425,340 |
| Non-Current Assets | |||||
| PPE Net | 3,349,000 | 3,128,089 | 2,792,106 | 2,230,957 | 2,091,404 |
| Investments And Advances | 1,449,000 | 1,242,866 | 901,052 | 800,395 | 1,115,327 |
| Intangibles | 1,889,000 | 1,902,930 | 1,918,975 | 1,950,235 | 1,983,410 |
| Other Non-Current Assets | 1,074,000 | 1,030,843 | 998,672 | 964,561 | 787,914 |
| TOTAL | $7,761,000 | $7,304,728 | $6,610,805 | $5,946,148 | $5,978,055 |
| Total Assets | $12,147,000 | $12,099,310 | $10,546,610 | $9,699,469 | $9,403,395 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 339,000 | 193,321 | 45,629 | 101,869 | 104,832 |
| Other current liabilities | N/A | 1,082,553 | 1,051,261 | 910,056 | N/A |
| TOTAL | $1,660,000 | $1,354,938 | $1,141,735 | $1,292,503 | $1,238,030 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,083,000 | 2,087,538 | 485,250 | 456,250 | 412,250 |
| Deferred Revenues | 44,000 | 44,586 | 44,845 | 45,995 | 45,989 |
| Other Non-Current Liabilities | 714,000 | 697,430 | 692,428 | 688,271 | 703,120 |
| TOTAL | $3,017,000 | $3,021,110 | $1,424,870 | $1,402,955 | $1,383,175 |
| Total Liabilities | $4,677,000 | $4,376,048 | $2,566,605 | $2,695,458 | $2,621,205 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,053,872 | 1,054,512 | 1,064,283 | 1,056,451 | 1,046,300 |
| Common Shares | 21,000 | 21,163 | 21,248 | 20,964 | 20,943 |
| Retained earnings | -2,067,000 | -1,569,389 | -1,087,327 | -1,379,077 | -1,532,455 |
| Other shareholders' equity | 253,000 | 259,146 | 272,967 | 227,062 | 290,948 |
| TOTAL | $7,470,000 | $7,723,258 | $7,980,005 | $7,004,011 | $6,782,190 |
| Total Liabilities And Equity | $12,147,000 | $12,099,306 | $10,546,610 | $9,699,469 | $9,403,395 |